Abbott Korea, Esai Korea co-promote Humira Pen

Abbott Korea and Esai Korea said they are co-marketing Humira Pen, a new device for administering Humira (adalimumab), a treatment approved for moderate to severe rheumatoid arthritis and psoriatic arthritis.

With its one-touch activation and easy-to-grasp size and shape, the Humira Pen offers improved ease of use for these patients, many of whom may have swelling or stiffness in the hands. ...